Periscope Capital’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,462,105
Closed -$14.7M 820
2022
Q4
$14.7M Buy
1,462,105
+399,727
+38% +$3.97M 0.63% 9
2022
Q3
$10.4M Buy
1,062,378
+30,978
+3% +$304K 0.3% 81
2022
Q2
$10.1M Buy
1,031,400
+800
+0.1% +$7.83K 0.27% 93
2022
Q1
$10.1M Sell
1,030,600
-500
-0% -$4.86K 0.26% 94
2021
Q4
$10M Buy
1,031,100
+232,500
+29% +$2.26M 0.27% 93
2021
Q3
$7.75M Buy
+798,600
New +$7.74M 0.23% 148

Other funds holding AONC

Periscope Capital's AONC Position: Q1 2023 in Review

Periscope Capital sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 1,462,105 shares — an estimated $14.7M sold.

Periscope Capital first reported a position in AONC in Q3 2021 and held it in 6 quarters. The position peaked at $14.7M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Periscope Capital reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Periscope Capital sold 1,462,105 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $14.7M.
  • Periscope Capital first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 6 quarters.
  • Periscope Capital's American Oncology Network, Inc. Class A Common Stock position peaked at $14.7M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Periscope Capital's 13F filing for Q1 2023, filed 12 May 2023.